WHO ICTRP trial
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease…
JPRN-jRCT2031210044 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031210044 |
|---|---|
| Public title | A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease (SURMOUNT-J) |
| Scientific title | Efficacy and Safety of Once Weekly Tirzepatide in Participants with Obesity Disease: A Randomized, Double Blind, Placebo Controlled Trial (SURMOUNT-J) - I8F-JE-GPHZ |
| Primary sponsor | Masaki Takeshi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Obesity Disease |
| Interventions | Tirzepatide Regimen A administered subcutaneously (SC) Tirzepatide Regimen B administered SC Placebo administered SC |
| Registration date | Apr 21, 2021 |
| Target size | 261 |
| Secondary IDs | NCT04844918 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: